title: Gastrointestinal cancers in the era of theranostics: Updates and future perspectives.
abstract: Theranostics are one of the practical aspects of personalized medicine. This concept was designed to describe a material combining diagnosis, treatment and follow up of a disease. It evolved and included molecular targeting and nanotechnologies that incorporate both diagnosis and therapeutics. In this editorial, we are presenting briefly the concept and evolution of theranostics, highlighting many applications of theranostics in daily practice and discussing future perspectives and aspects of this model in gastro-intestincal cancers.
authors.affiliation: Marwan Ghosn, Hampig Raphael Kourie, Samer Tabchi, Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: Marwan
authors.initials: M
authors.lastname: Ghosn
authors.affiliation: Marwan Ghosn, Hampig Raphael Kourie, Samer Tabchi, Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: Hampig Raphael
authors.initials: HR
authors.lastname: Kourie
authors.affiliation: Marwan Ghosn, Hampig Raphael Kourie, Samer Tabchi, Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
authors.forename: Samer
authors.initials: S
authors.lastname: Tabchi
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D004059:Diffusion of Innovation; D005544:Forecasting; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D020022:Genetic Predisposition to Disease; D006801:Humans; D025202:Molecular Diagnostic Techniques; D058990:Molecular Targeted Therapy; D010641:Phenotype; D011237:Predictive Value of Tests; D000068936:Theranostic Nanomedicine / Q000639:trends; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor
keywords: Gastrointestinal cancer; Molecular targeting; Nanoparticles; Nanotheranostics; Theranostics